Appropriate duration of dual antiplatelet therapy still unclear

A systematic review of published evidence does little to clarify the appropriate duration of dual antiplatelet therapy following drug eluting stent placement. The evidence suggests that longer duration therapy decreases the risk for myocardial infarction, but increases the risk for major bleeding events, and may provide a slight increase in mortality.